Dilemmas in the compassionate supply of investigational cancer drugs

J. R. R. Lewis*, W. Lipworth, I. Kerridge, E. Doran

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)


In Australia, patients who want to access medicines that are not yet approved have only two options: to enroll in a clinical trial if they are eligible, or obtain their medicine through 'compassionate supply', which is provided at the discretion of the manufacturer. In this article, we explore ethical issues associated with the provision of oncology medicines that are still in development, either prior to regulatory approval or government reimbursement.

Original languageEnglish
Pages (from-to)841-845
Number of pages5
JournalInternal Medicine Journal
Issue number9
Publication statusPublished - Sep 2014
Externally publishedYes


  • ethics
  • evidence-based medicine
  • health services accessibility
  • oncology

Cite this